Amy Janes is an American psychiatry researcher. She is chief of the Cognitive and Pharmacological Neuroimaging Unit at the National Institute on Drug Abuse's Intramural Research Program.[1][2] She is known for her work using multimodal neuroimaging to examine individual differences and potential therapeutics in addictive and substance use disorders. Prior to joining NIDA, Janes was an associate professor at Harvard Medical School, working at McLean Hospital, where she founded the Functional Integration of Addiction Research Laboratory.[3]
In 2001 Janes received a B.A. from Rutgers University. In 2003 she received an M.A. from Boston University, going on to complete her Ph.D. there in 2007. She then joined the faculty at McLean Hospital in 2007, remaining until 2021 when she joined NIDA.[2]
Professional honors and duties
Janes has been awarded numerous professional honors, including:
2010, Alfred Pope Award for Young Investigators[4]
Janes's work in clinical neuroimaging research focuses on substance use disorders. Her research primarily utilizes multimodal neuroimaging techniques to explore various aspects of addiction, including identifying individual vulnerabilities to addiction, evaluating the impact of potential therapeutics on brain function, investigating the interplay between psychiatric disorders and nicotine dependence, and advancing the basic neuroscience understanding of substance use disorders. Her long-term objective is to use neuroscience in guiding the creation of personalized treatments for substance abuse disorders.[2]
Selected publications
Janes has more than 2,400 citations in Google Scholar and an h-index of 29.[10]
Janes is married[11] to Robert Ross, a professor at Johns Hopkins University.[12] She is the daughter of Harry Janes, emeritus professor at Rutgers University.[13]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.